Effects of monoamine oxidase inhibitors on isoproterenol-induced cardiomegaly in rats. 1970

H C Stanton, and Z Bowman, and C M Cooper

UI MeSH Term Description Entries
D007520 Isocarboxazid An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009526 Nialamide An MAO inhibitor that is used as an antidepressive agent.
D009696 Nucleic Acids High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages. Nucleic Acid,Acid, Nucleic,Acids, Nucleic
D010293 Pargyline A monoamine oxidase inhibitor with antihypertensive properties. Pargyline Hydrochloride,Hydrochloride, Pargyline
D010624 Phenelzine One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC. Fenelzin,2-Phenethylhydrazine,Nardelzine,Nardil,Phenelzine Sulfate,Phenethylhydrazine,beta-Phenylethylhydrazine,2 Phenethylhydrazine,Sulfate, Phenelzine,beta Phenylethylhydrazine
D010880 Piperidines A family of hexahydropyridines.

Related Publications

H C Stanton, and Z Bowman, and C M Cooper
January 1966, Proceedings of the Western Pharmacology Society,
H C Stanton, and Z Bowman, and C M Cooper
January 1969, American heart journal,
H C Stanton, and Z Bowman, and C M Cooper
November 2005, Neurochemical research,
H C Stanton, and Z Bowman, and C M Cooper
March 2006, Behavioural pharmacology,
H C Stanton, and Z Bowman, and C M Cooper
October 1960, Biochemical pharmacology,
H C Stanton, and Z Bowman, and C M Cooper
January 1979, Proceedings of the Western Pharmacology Society,
H C Stanton, and Z Bowman, and C M Cooper
January 1985, Clinical and experimental pharmacology & physiology,
H C Stanton, and Z Bowman, and C M Cooper
September 1967, The Journal of pharmacology and experimental therapeutics,
H C Stanton, and Z Bowman, and C M Cooper
January 1972, Bulletin of the Menninger Clinic,
H C Stanton, and Z Bowman, and C M Cooper
June 1969, Nature,
Copied contents to your clipboard!